Type-2 diabetes primary prevention program implemented in routine primary care: a process evaluation study

Table 3 One-way adjusted associations between implemented program procedures and strategies, and recruitment and intervention completion process indicators

Variable	Reach of the screening^a	Efficiency of the screening^b	Refusal rate^b	Completion of intervention^b
Massive screening strategies	0.69 (0.19–2.50)	0.57 (0.26–1.23)	2.34 (1.08–5.07)	N.A.
Targeted screening strategy	0.36 (0.11–0.86)	3.2 (2.08–4.93)	0.29 (0.18–0.47)	N.A.
Additional appointment for informed consent	N.A.	N.A.	3.34 (1.36–8.21)	N.A.
Baseline test offered on only one specific day	N.A.	N.A.	0.73 (0.08–6.59)	N.A.
Blood test out of center	N.A.	N.A.	2.15 (0.81–5.75)	N.A.
Intervention offered at one time of day only	N.A.	N.A.	N.A.	0.72 (0.40–1.30)

Values are odds ratios (95 % confidence interval); N.A. not applicable, ^aModel 1: adjusted for patient-level variables (age, sex, co-morbidity) and center-level variables (percentage of family physicians and nurses adopting the program) and center random effect, ^bModel 2: same adjustment as ^a, but including body mass index within patient-level variables. Center random effect in all tested models p <0.001

ISSN: 1745-6215